In my research I am studying new magnetic resonance imaging biomarkers for pediatric brain tumors. I am also investigating the application of AI in digital pathology and imaging as well as mapping of genetic and epigenetic predisposition to cancer.
I am Senior Consultant in Pediatric Oncology. Head of pediatric neurooncology in the Southeast Healthcare Region.
Per Nyman
Ongoing PhD project where I am studying new magnetic resonance imaging biomarkers for pediatric brain tumors.
Presentation
About me
CV
- 2021 PhD Student Medical Radiophysics, Linköping University and Center for Medical Image Science and Visualization (CMIV) Research School
- 2019 Specialist in Pediatric Oncology and Hematology, Linköping University Hospital: 2019 August 30
- 2015 Specialist in Pediatrics, Linköping University Hospital: 2015 May 21
- 2009 Doctor of Medicine, Linköping University Hospital /Motala Hospital: 2009 June 26
- 2007 Bachelor of medicine and surgery, Lund University, Sweden: 2007 June 8
Education
Teaches pediatric oncology at the Medical Program, K10, LiU
Network
- Swedish Society of Medicine
- Nordic Society of Pediatric Hematology and Oncology (NOPHO)
- VCTB, Working group on CNS tumors in children, Sweden
- NOPHO Brain tumor group
- The European Society for Paediatric Oncology, SIOPe Craniopharyngioma Working Group
- Member of the steering group of the Swedish Childhood Tumor Biobank (Barntumörbanken, BTB)
- Member of the Nomination Committee for the Swedish Childhood Cancer Fund (Barncancerfonden) priority committees
- Member of NB CNS (Network for Neuroblastoma and CNS Tumor Research in Children) steering group
Publications
2025
Continue to DOI
Continue to DOI
Continue to DOI
Continue to DOI
Continue to DOI
Research
Brain Tumours in Children (BAQA; BAQA-18) (Novel imaging biomarkers for magnetic resonance of brain tumours);
Application of AI in Digital pathology and Imaging;
OncoABIS: Mapping genetic and epigenetic predisposition to cancer
Application of AI in Digital pathology and Imaging;
OncoABIS: Mapping genetic and epigenetic predisposition to cancer